| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Ispinesib |
伊斯平斯 |
336113-53-2 |
详细
|
| NVP-TAE684 |
NVP-TAE684 |
761439-42-3 |
详细
|
| 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE, 7-METHYL-2-(4-MORPHOLINYL)-9-[1-(PHENYLAMINO)ETHYL]- |
(+/-)-7-甲基-2-(吗啉-4-基)-9-(1-苯基氨基乙基)吡啶并[1,2-A]嘧啶-4-酮 |
663619-89-4 |
详细
|
| AT9283 |
AT9283 |
896466-04-9 |
详细
|
| BMS-754807 |
BMS-754807 |
1001350-96-4 |
详细
|
| Savolitinib |
沃利替尼 |
1313725-88-0 |
详细
|
| LJH685 |
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚 |
1627710-50-2 |
详细
|
| Lys05 |
Lys05 |
1391426-24-6 |
详细
|
| T0901317 |
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺 |
293754-55-9 |
详细
|
| IMD-0354 |
N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺 |
978-62-1 |
详细
|
| SU 6656 |
SU 6656 |
330161-87-0 |
详细
|
| Hesperadin |
HESPERADIN |
422513-13-1 |
详细
|
| 1H-Pyrazole-1-ethanol, 4-[(1E)-2-[5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]- |
LY2874455 |
1254473-64-7 |
详细
|
| SF1670 |
SF1670(PTENINHIBITOR) |
345630-40-2 |
详细
|
| ML-323 |
ML323 |
1572414-83-5 |
详细
|
| Cl-amidine TFA |
Cl-Amidine |
1043444-18-3 |
详细
|
| CCT245737 |
CCT245737 |
1489389-18-5 |
详细
|
| LF3 |
LF3 |
664969-54-4 |
详细
|
| Imaradenant (AZD4635) |
AZD4635 |
1321514-06-0 |
详细
|
| Topotecan |
拓扑替康 |
123948-87-8 |
详细
|
| Apigenin |
芹菜素 |
520-36-5 |
详细
|
| CM-272 |
化合物CM-272 |
1846570-31-7 |
详细
|
| TTNPB |
TTNPB (Arotinoid Acid) |
71441-28-6 |
详细
|
| YM201636 |
6-氨基-N-[3-[4-(4-吗啉基)吡啶并[3',2':4,5]呋喃并[3,2-D]嘧啶-2-基]苯基]-3-吡啶甲酰胺 |
371942-69-7 |
详细
|
| OSU-03012 (AR-12) |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 |
742112-33-0 |
详细
|
| PF-04691502 |
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
详细
|
| 4-Quinazolinamine, 2-cyclohexyl-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]- |
UNC0638 |
1255580-76-7 |
详细
|
| Afuresertib |
GSK-2110183C |
1047644-62-1 |
详细
|
| STF-083010 |
STF 083010 |
307543-71-1 |
详细
|
| AZ191 |
DYRK1B抑制剂(AZ191) |
1594092-37-1 |
详细
|
| IM-12 |
IM-12 |
1129669-05-1 |
详细
|
| Mivebresib |
米维布塞 |
1445993-26-9 |
详细
|
| MI-503 |
MI-503 |
1857417-13-0 |
详细
|
| Asciminib |
ABL-001 |
1492952-76-7 |
详细
|
| INCB13739 |
玛伐凯泰 |
1642288-47-8 |
详细
|
| LXH254 |
LXH254 |
1800398-38-2 |
详细
|
| BMS-1166 |
BMS-1166 |
1818314-88-3 |
详细
|
| MYCi361 |
MYCI361 |
2289690-31-7 |
详细
|
| Marimastat |
马立马司他 |
154039-60-8 |
详细
|
| STAT5-IN-1 |
STAT5 Inhibitor |
285986-31-4 |
详细
|
| Pracinostat |
(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 |
929016-96-6 |
详细
|
| SRT 2104 |
玻玛西林 |
1093403-33-8 |
详细
|
| Vorapaxar |
沃拉帕沙 |
618385-01-6 |
详细
|
| AZ20 |
AZ20 |
1233339-22-4 |
详细
|
| 2-D08 |
化合物2-D08 |
144707-18-6 |
详细
|
| SEL120-34A HCl |
1609452-30-3 |
1609452-30-3 |
详细
|
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
详细
|
| Zelavespib (PU-H71) |
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
873436-91-0 |
详细
|
| Nirogacestat |
PF-3084014 |
1290543-63-3 |
详细
|
| SR-18292 |
2095432-55-4 |
2095432-55-4 |
详细
|
| C-178 |
N-(二苯并[B,D]呋喃-3-基)-5-硝基呋喃-2-甲酰胺 |
329198-87-0 |
详细
|
| SR-717 |
SR-717 |
2375421-09-1 |
详细
|
| Nelfinavir Mesylate |
甲磺酸奈非那韦 |
159989-65-8 |
详细
|
| GSK650394 |
2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
详细
|
| AUZ-454 |
K03861 |
853299-07-7 |
详细
|
| FPS-ZM1 |
N-BENZYL-4-CHLORO-N-CYCLOHEXYLBENZAMIDE |
945714-67-0 |
详细
|
| AZD5582 |
AZD 5582 |
1258392-53-8 |
详细
|
| WZB117 |
WZB-117 |
1223397-11-2 |
详细
|
| E6446 dihydrochloride |
CS-2089 |
1345675-25-3 |
详细
|
| GSK2982772 |
GSK2982772 |
1622848-92-3 |
详细
|
| MSA-2 |
MSA-2 |
129425-81-6 |
详细
|
| Silibinin |
水飞蓟宾 |
22888-70-6 |
详细
|
| IBMX |
3-异丁基-1-甲基黄嘌呤 |
28822-58-4 |
详细
|
| Dubermatinib |
TP-0903 |
1341200-45-0 |
详细
|
| Unesbulin |
PTC596 |
1610964-64-1 |
详细
|
| Pitavastatin Calcium |
匹伐他汀钙 |
147526-32-7 |
详细
|
| Lonidamine |
氯尼达明 |
50264-69-2 |
详细
|
| NDI-091143 |
NDI-091143 |
2375840-87-0 |
详细
|
| Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)- |
硝唑尼特 |
55981-09-4 |
详细
|
| PHA-665752 |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
详细
|
| FR 180204 |
FR180204 |
865362-74-9 |
详细
|
| ML-141 |
ML 141 |
71203-35-5 |
详细
|
| A-1210477 |
无中文名称 |
1668553-26-1 |
详细
|
| 3BDO |
3BDO, MTOR激酶激活剂, 自噬抑制剂 |
890405-51-3 |
详细
|
| Cholesterol |
胆固醇 |
57-88-5 |
详细
|
| Monensin sodium salt |
莫能菌素钠盐 |
22373-78-0 |
详细
|
| Sirtinol |
2-[[(2-羟基-1-萘基)亚甲基]氨基]-N-(1-苯基乙基)苯甲酰胺 |
410536-97-9 |
详细
|
| Ampicillin sodium |
氨苄西林钠 |
69-52-3 |
详细
|
| Omeprazole |
奥美拉唑 |
73590-58-6 |
详细
|
| PNU-74654 |
PNU 74654,2-PHENOXYBENZOICACID-[(5-METHYL-2-FURANYL)METHYLENE]HYDRAZIDE |
113906-27-7 |
详细
|
| 1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo- |
艾沙佐米柠檬酸盐 |
1201902-80-8 |
详细
|
| EHop-016 |
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE |
1380432-32-5 |
详细
|
| TMP269 |
TMP269 |
1314890-29-3 |
详细
|
| AdipoRon |
阿迪普隆 |
924416-43-3 |
详细
|
| PHA-767491 hydrochloride |
1,5,6,7-四氢-2-(4-吡啶基)-4H-吡咯并[3,2-C]吡啶-4-酮盐酸盐 |
942425-68-5 |
详细
|
| GDC-0575 |
(R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)环丙烷甲酰胺 |
1196541-47-5 |
详细
|
| KYA1797K |
CS-2581 |
1956356-56-1 |
详细
|
| Repotrectinib |
洛普替尼 |
1802220-02-5 |
详细
|
| Autophinib |
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE |
1644443-47-9 |
详细
|
| EX229 |
EX229 |
1219739-36-2 |
详细
|
| Geldanamycin |
格尔德霉素 |
30562-34-6 |
详细
|
| ZM 447439 |
ZM 447439 |
331771-20-1 |
详细
|
| PJ34 hydrochloride |
PJ34 |
344458-15-7 |
详细
|
| Cisapride |
西沙必利 |
81098-60-4 |
详细
|
| MI 2 |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
详细
|
| Ruboxistaurin hydrochloride |
鲁伯斯塔盐酸盐 |
169939-93-9 |
详细
|
| U-104 |
U-104 |
178606-66-1 |
详细
|
| Compound 3i (666-15) |
1433286-70-4 |
1433286-70-4 |
详细
|
| KI16425 |
KI16425 |
355025-24-0 |
详细
|
| MYCi975 |
MYCi975 |
2289691-01-4 |
详细
|